Market Overview:
The global Bactroban ointment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of skin infections, rising awareness about hygiene and sanitation, and growing demand for over-the-counter (OTC) drugs. Based on type, the global Bactroban ointment market can be segmented into below 10g, 10g-20g, and above 20g segments. The below 10g segment is expected to account for a major share of the global Bactroban ointment market in 2018 owing to its low price point and easy availability. However, the above 20g segment is projected to grow at a higher CAGR during the forecast period due to its high efficacy in treating skin infections. Based on application, the global Bactroban ointment market can be divided into hospital pharmacy, retail pharmacy, and other segments. The hospital pharmacy segment is anticipated to hold a dominant position in this market throughout the forecast period as hospitals are increasingly adopting novel therapies for treating various skin infections caused by multi-drug resistant bacteria strains.
Product Definition:
Bactroban ointment is a prescription medication used to treat skin infections. It is a topical antibiotic that works by killing the bacteria that cause the infection. Bactroban ointment may also be used to prevent infection in minor cuts or burns.
Below 10g:
Below 10g, it's usage.
Below 10 g is the lowest concentration of any bacitracin/neomycin/polymyxin combination. It is used for skin and soft tissue infections.
10g-20g:
Bactroban Ointment is used for skin-related problems like rashes, cuts, and burns. It is also used to treat infections caused by acne or breakouts. Bactroban Ointment contains the active ingredient that helps in killing bacteria which causes infection. The ointment also includes a corticosteroid which reduces redness and swelling along with other antihistamines that help in relieving itching caused due to sensitive skin or from an infected area.
Application Insights:
The other application segment includes skin infections, burns and wounds, diaper rash, insect bites and stings. Bactroban ointment is majorly used for skin infections as it works by killing the bacteria that cause infection. The hospital pharmacy segment dominated the global market in 2017 owing to increasing number of hospital admissions worldwide due to rising cases of chronic diseases such as diabetes and respiratory disorders. This has created a significant demand for antiseptic creams that help prevent skin infections caused by Staphylococcus aureus or any other microorganisms.
The hospital pharmacy segment is expected to continue its dominance over the forecast period owing to high usage rates of bacitracin zinc cream in hospitals across various parts of the world especially in countries like India where there has been an increase in prevalence rate for acute respiratory diseases during winters season which usually lasts from November till March every year.
Regional Analysis:
North America was the largest regional market in 2017 owing to high consumer awareness and availability of advanced healthcare facilities. The region is expected to maintain its dominance during the forecast period due to increasing incidence of skin diseases coupled with rising adoption of western culture and lifestyle. Asia Pacific is projected to be the fastest-growing region over the forecast period owing to rapid economic development, improving healthcare infrastructure, growing medical tourism industry, and an increase in disposable income levels. In addition, rising prevalence of chronic diseases such as diabetes & eczema will drive product demand further.
The bactroban ointment market has been segmented on a geographical basis into North America; Europe; Asia Pacific (excluding Japan); Central & South America (CSA) including Middle East Africa (MEA); and Japan).
Growth Factors:
- Increasing incidence of skin infections: The increasing incidence of skin infections is one of the key growth drivers for the Bactroban ointment market. This is because Bactroban ointment is a highly effective drug against various types of skin infections.
- Rising awareness about the benefits of Bactroban ointment: The rising awareness about the benefits of using Bactroban ointment is another key growth driver for this market. This is because people are becoming increasingly aware about its efficacy in treating various types of skin infections.
- Growing demand for topical antibiotics: The growing demand for topical antibiotics across the globe is another major factor driving the growth of this market. This is because topical antibiotics are considered to be more effective than oral antibiotics in treating certain typesofskininfections,such as impetigo and MRSA infection .
Scope Of The Report
Report Attributes
Report Details
Report Title
Bactroban Ointment Market Research Report
By Type
Below 10g, 10g-20g, Above 20g
By Application
Hospital Pharmacy, Retail Pharmacy, Other
By Companies
Glenmark Pharms, Glaxosmithkline, SmithKline & French, Humanwell Healthcare, Taro Pharmaceutical, Teva, Perrigo, Hanzhou Zhuyangxin Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Bactroban Ointment Market Report Segments:
The global Bactroban Ointment market is segmented on the basis of:
Types
Below 10g, 10g-20g, Above 20g
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Glenmark Pharms
- Glaxosmithkline
- SmithKline & French
- Humanwell Healthcare
- Taro Pharmaceutical
- Teva
- Perrigo
- Hanzhou Zhuyangxin Pharmaceutical
Highlights of The Bactroban Ointment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Below 10g
- 10g-20g
- Above 20g
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bactroban Ointment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bactroban Ointment is a topical antibiotic ointment used to treat skin infections. It is available over the counter and is typically used to treat minor skin infections such as impetigo, eczema, or folliculitis. Bactroban Ointment should not be used on open wounds or areas of active infection.
Some of the major players in the bactroban ointment market are Glenmark Pharms, Glaxosmithkline, SmithKline & French, Humanwell Healthcare, Taro Pharmaceutical, Teva, Perrigo, Hanzhou Zhuyangxin Pharmaceutical.
The bactroban ointment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bactroban Ointment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bactroban Ointment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bactroban Ointment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bactroban Ointment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bactroban Ointment Market Size & Forecast, 2020-2028
4.5.1 Bactroban Ointment Market Size and Y-o-Y Growth
4.5.2 Bactroban Ointment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Below 10g
5.2.2 10g-20g
5.2.3 Above 20g
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bactroban Ointment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bactroban Ointment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Below 10g
9.6.2 10g-20g
9.6.3 Above 20g
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacy
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Below 10g
10.6.2 10g-20g
10.6.3 Above 20g
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacy
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Below 10g
11.6.2 10g-20g
11.6.3 Above 20g
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacy
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Below 10g
12.6.2 10g-20g
12.6.3 Above 20g
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacy
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Below 10g
13.6.2 10g-20g
13.6.3 Above 20g
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacy
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bactroban Ointment Market: Competitive Dashboard
14.2 Global Bactroban Ointment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Glenmark Pharms
14.3.2 Glaxosmithkline
14.3.3 SmithKline & French
14.3.4 Humanwell Healthcare
14.3.5 Taro Pharmaceutical
14.3.6 Teva
14.3.7 Perrigo
14.3.8 Hanzhou Zhuyangxin Pharmaceutical
